Skip to content
Moderna’s personalized mRNA melanoma vaccine achieves positive results
In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its ...
Read More
COVID-19 vaccines two years later: 3 million lives and a trillion dollars saved
When nurse Sandra Lindsay received the first dose of the COVID-19 vaccine in ...
Read More
BIO urges Senate to confirm agricultural trade officials
It is time for the Senate to confirm two officials tasked with protecting ...
Read More
Data shows persistent inequities in U.S. COVID treatment trials, rare disease R&D
The lack of gender and racial diversity in medical R&D in the United ...
Read More
WHO report warns of the rise in antibiotic resistance, seeks better data
Common bacterial infections are becoming increasingly resistant to antibiotics, “causing life-threatening bloodstream infections,” ...
Read More
Mexico’s treatment of biotech corn needs urgent action, U.S. lawmakers say
Ahead of a key meeting between the U.S. and Mexico later this week, ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...
Federal Policy
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and runs through Dec. 7. “As patient advocates have seen year after ...
BIO Events
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11 BIO ...
BIO Events
Ahead of BIO IP Conference, research highlights why biotech needs strong patents
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship between ...
BIO Events
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts on ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures ...
Read More
International
Bio's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely ...
Read More
